Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Anticipated Size Of The Opioid Use Disorder (OUD) Market Over The Five-Year Period 2025–2029?
The market size for opioid use disorder (oud) has expanded quickly over recent years. It is anticipated to expand from $3.96 billion in 2024 to $4.37 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.5%. The historical growth of this market can be linked to several factors, including heightened prescription rates, prevailing pain management practices, pharmaceutical marketing efforts, and the societal stigmatization associated with addiction.
The market for opioid use disorder (OUD) is projected to experience substantial growth in the upcoming years. It is anticipated to reach “$6.91 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is primarily driven by factors such as regulatory actions, an increased emphasis on alternative methods for pain management, broadened access to treatment, and various public health programs. Key trends expected over the forecast horizon encompass technological advancements in therapeutic solutions, personalized approaches to treatment, models of integrated care, support programs within communities, and strategies for early intervention and prevention.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Opioid Use Disorder (OUD) Industry?
The increasing number of opioid addiction cases is projected to stimulate the expansion of the opioid use disorder (OUD) market moving forward. Opioid addiction is characterized as a medical condition involving the compulsive and prolonged use of opioids, which has damaging effects on the body. Opioids are known to induce feelings of euphoria and pain relief, but their continuous consumption can lead to the development of tolerance, requiring higher doses to achieve the same effect, potentially resulting in opioid use disorder. For example, in March 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the rate of synthetic opioid drug overdosage increased by 4.1%, rising from 21.8 to 22.7 between 2021 and 2022. Therefore, the growing incidence of opioid addiction cases is a significant factor driving the growth of the opioid use disorder (OUD) market.
How Is The Opioid Use Disorder (OUD) Market Segmented?
The opioid use disorder (oud)market covered in this report is segmented –
1) By Drug Type: Buprenorphine; Naltrexone; Methadone
2) By Route of Administration: Oral; Parenteral
3) By Age Group: 19 To 40; 41 To 60; 61 And Over
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Stores; Online Pharmacies
Subsegments:
1) By Buprenorphine: Suboxone; Buprenorphine Tablets; Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets; Vivitrol
3) By Methadone: Methadone Tablets; Methadone Oral Solution
What Trends Are Expected To Drive The Opioid Use Disorder (OUD) Market?
A prominent and growing trend within the Opioid Use Disorder (OUD) market is product innovation. Major companies engaged in the Opioid Use Disorder (OUD) market are introducing innovative products to uphold their market presence. For example, in May 2023, the U.S. Food and Drug Administration, a federal agency based in the US, authorized Brixadi (buprenorphine) extended-release injection for addressing moderate to severe Opioid Use Disorder (OUD). Brixadi comes in two distinct dosage forms: a weekly injection for patients who started treatment with a single dose of a transmucosal buprenorphine product or are currently using the medication, and a monthly version for those already on the medication.
Which Leading Companies Dominate The Opioid Use Disorder (OUD) Market Share?
Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Opioid Use Disorder (OUD) Market?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Opioid Use Disorder (OUD) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp
Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2025, By The Business Research Company
Used Truck Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/used-truck-global-market-report
Used Cars Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/used-cars-global-market-report
Non Opioid Pain Patch Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model